NKX3-1 and central nervous system cancer: As shown in Figure 6B, lncRNA NKX3-1 overexpression significantly reduced the apoptotic ability of glioma cells compared to the control group (P <0.05), whereas lncRNA NKX3-1 knockdown significantly increased the apoptotic ability of glioma cells (P <0.05).